SSY Group Limited, formerly Lijun International Pharmaceutical (Holding) Co., Ltd., is an investment holding company. The Company, along with its subsidiaries, is engaged in the research, development, manufacturing and selling of a range of finished medicines and bulk pharmaceutical products to hospitals and distributors. The Company has manufacturing plants in Hebei Province and Shaanxi Province, the People's Republic of China and sells to customers principally in Mainland China. The Company's segments include intravenous infusion solution, and antibiotics and others. Its subsidiaries include New Orient Investments Limited, Shijiazhuang No.4 Pharmaceutical Co., Ltd., Xi'an Lijun Pharmaceutical Co., Ltd., Shenzhen Lijun Pharmaceutical Co., Ltd., Hebei Jin men Pharmaceutical Import & ExportCo., Ltd., Hebei Guolong Pharmaceutical Co., Ltd. and others.